Is Johnson & Johnson (JNJ) The Most Profitable Healthcare Stock To Buy? [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
Johnson & Johnson (NYSE:JNJ) to $250, up from $222, and maintained a Buy rating, citing the company's fourth quarter results. The revised price target reflects an upside potential of approximately 14%. According to the firm, the initial projection of Johnson & Johnson (NYSE:JNJ) should uplift the consensus revenue and EPS forecasts for the healthcare powerhouse. From this year and beyond, the company's Pharmaceutical and Medical Devices franchises are expected to continue their growth trajectory, TD Cowen noted. Trong Nguyen / Shutterstock.com On the same day, several other analysts updated their outlooks to better reflect the company's Q4 performance, which exceeded market estimates with $24.6 billion in revenue. BofA Securities also slightly raised its price target on Johnson & Johnson (NYSE:JNJ) from $220 to $221 and reiterated a Neutral rating on the stock. The company's financial results were described as “solid” by the firm, which attributes it to the growth drivers, parti
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF SymposiumBusiness Wire
- BofA Lifts PT on Johnson & Johnson (JNJ) to $227 From $221 – Here's Why [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson's Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy? [Yahoo! Finance]Yahoo! Finance
- Alcon's Precision7 Weekly Lenses Test Comfort Claims And Growth Hopes [Yahoo! Finance]Yahoo! Finance
- 5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 1/21/26 - Beat
JNJ
Sec Filings
- 2/6/26 - Form 4
- 2/5/26 - Form 144
- 2/5/26 - Form SCHEDULE
- JNJ's page on the SEC website